Bonus plan for ALO

Quote
I'm not launching the drug but hope everyone does well. If not, sitting by the phone will be the plan for January restructure. Good luck everyone. The whole company is hinged on these subpar drugs.

Roll Tide
 








Anonymous said:
There is no way in hell this is correct. $280 per Rx? Please.
Click to expand...

My goal is 8 Rx for the quarter. Comes out to $350 per Rx that I will make. Obvious that the company wants to hit it hard first twelve weeks and is willing to put money to make it worth reps time.
Thanks Takeda! You got it right this time.
 




Anonymous said:
My goal is 8 Rx for the quarter. Comes out to $350 per Rx that I will make. Obvious that the company wants to hit it hard first twelve weeks and is willing to put money to make it worth reps time.
Thanks Takeda! You got it right this time.
Click to expand...

Let's see. We get Takeda meds for free and receive sales credit for it. Getting a script for yourself, will net you $1030 alone.
 




carcinogenesis is a class effect among the TZD's, just as water retention that causes CHF is a TZD class effect. However, compared to Avandia, Actos patients exhibit a cancer reporting rate in the AERS four times higher than Avandia patients. A possible explanation is that Actos is a salt-based chemical preparation with benzenesulfonate involved in the salt’s crystal formation, and its post-decomposition chemical particles are not totally biodegradable, resulting in excess benzene exposure, i.e. non-biodegraded toxic chemicals such as benzene remain in circulated blood and suppressed bone marrow and immune cells leading to cancer formations. On the other hand, Avandia is an ester-based chemical prepara- tion, with most of its chemical ingredients largely biodegraded and excreted during decompose- tion/metabolism, resulting in a lesser exposure to benzene. Since Avandia cancers/neoplasms appear to be reported at a lower rate than those reported for Actos, it is possible that carcino- genesis is one of the TZDs’ class effects depending on how the chemical compound was structured and formulated.
 




Anonymous said:
carcinogenesis is a class effect among the TZD's, just as water retention that causes CHF is a TZD class effect. However, compared to Avandia, Actos patients exhibit a cancer reporting rate in the AERS four times higher than Avandia patients. A possible explanation is that Actos is a salt-based chemical preparation with benzenesulfonate involved in the salt’s crystal formation, and its post-decomposition chemical particles are not totally biodegradable, resulting in excess benzene exposure, i.e. non-biodegraded toxic chemicals such as benzene remain in circulated blood and suppressed bone marrow and immune cells leading to cancer formations. On the other hand, Avandia is an ester-based chemical prepara- tion, with most of its chemical ingredients largely biodegraded and excreted during decompose- tion/metabolism, resulting in a lesser exposure to benzene. Since Avandia cancers/neoplasms appear to be reported at a lower rate than those reported for Actos, it is possible that carcino- genesis is one of the TZDs’ class effects depending on how the chemical compound was structured and formulated.
Click to expand...

Yeaahhh....Avandia kills people, and is a "dead" drug itself.
 




Anonymous said:
My goal is 8 Rx for the quarter. Comes out to $350 per Rx that I will make. Obvious that the company wants to hit it hard first twelve weeks and is willing to put money to make it worth reps time.
Thanks Takeda! You got it right this time.
Click to expand...

Now that's a great way for a company to stay in business. Working here is like having an ATM machine in my kitchen!! I am never leaving.
 












Top Bottom
Back
Quote